Insider Sale: CHE CEO Disposes of 3,000 Shares at ~$461.28

Rhea-AI Filing Summary

Kevin J. McNamara, President, CEO and a director of Chemed Corporation (CHE), reported an open-market sale of 3,000 shares of Chemed common stock on 09/26/2025. The reported weighted-average sale price was $461.28 per share (transactions ranged from $460.03 to $462.44). After the sale the reporting person beneficially owned 96,197 shares. The Form 4 includes an offer to provide transaction-level price/volume details on request.

Positive

• None.

Negative

• Insider disposition: CEO and director sold 3,000 shares on 09/26/2025, reducing beneficial ownership to 96,197 shares.
• Sale disclosed without context: Form 4 does not state percentage of total holdings sold or use of proceeds, limiting investors' ability to assess intent.

Insights

Financial Analyst

TL;DR: Insider sale of 3,000 shares at ~$461.28 reduces holdings to 96,197 shares; transaction appears routine and not materially transformative.

The Form 4 discloses a single open-market disposition by CEO Kevin McNamara totaling 3,000 shares at a reported weighted-average price of $461.28 on 09/26/2025. The filing notes multiple execution prices within a narrow range, implying standard block sale execution rather than an exercise-related transfer. The sale represents a specified number of shares but the filing provides no context on percentage of total holdings or intended use of proceeds. Absent additional firmsize-relative metrics, this is a routine disclosure rather than a material corporate development.

Corporate Governance Expert

TL;DR: Director/CEO reported a small open-market sale; filing meets Section 16 disclosure requirements and includes explanatory footnote.

The submission satisfies Section 16 reporting by specifying the transaction date, quantity, weighted-average price and resulting beneficial ownership. Inclusion of a footnote offering granular trade details is good disclosure practice. There is no indication of related-party transactions or changes to control. From a governance perspective, the filing is compliant and transparent but provides limited information for assessing insider intent.

Insider Trade Summary

Net Seller: 3,000 shares

Net Sell 1 txn

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 3,000 shs ($1.38M)

Type	Security	Shares	Price	Value
Sale	Capital Stock	3,000	$461.28	$1.38M

Holdings After Transaction: Capital Stock — 96,197 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.03 to $462.44. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 09/29/2025 - 11:59 AM Learn about SEC filing dates

FAQ

What did CHE insider Kevin J. McNamara report on Form 4?

The filing reports an open-market sale of 3,000 Chemed shares on 09/26/2025 at a weighted-average price of $461.28, leaving 96,197 shares beneficially owned.

What price range did the CHE sale occur at?

The Form 4 footnote states transactions executed between $460.03 and $462.44, with a reported weighted-average price of $461.28.

What is Kevin McNamara's role at CHE as reported on the form?

The filing identifies Kevin J. McNamara as a Director and as an Officer with the title President and CEO.

Does the Form 4 indicate any derivative transactions or amendments?

No derivative securities or amendments are reported; the Form 4 only records the non-derivative sale of common stock on 09/26/2025.

Can investors obtain more granular trade details from the filer?

Yes. The reporting person states they will provide detailed information on the number of shares sold at each separate price within the disclosed range upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	09/26/2025		S		3,000	D	$461.28(1)	96,197	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.03 to $462.44. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.